Hyperbaric oxygenotherapy in the treatment of multiple sclerosis
Desola Alà, J.
Medicina Clinica 83(13): 562
1984
ISSN/ISBN: 0025-7753 PMID: 6513642 Document Number: 221690
Document emailed within 1 workday
Related Documents
Pallotta, R. 1982: Hyperbaric therapy of multiple sclerosis Minerva Medica 73(42): 2947-2954Golovkin, V.I.; Kuleshov, V.I.; Zaĭtsev, V.S. 1985: Hyperbaric oxygenation with hypercapnic mixture in multiple sclerosis Sovetskaia Meditsina 2: 22-26
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Webster, C.J.; MacIver, C.; Allen, S.; Murray, S. 1989: The chief scientist reports ... hyperbaric oxygen for multiple sclerosis patients Health Bulletin 47(6): 320-331
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Alonso, K.; Medenica, R. 1995: Immunomodulation in the treatment of multiple sclerosis and amyotrophic lateral sclerosis: a model for autoimmune disorders Journal of the National Medical Association 87(8): 561-568
Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Wührich, R. 1976: Treatment of multiple sclerosis Schweizerische Rundschau für Medizin Praxis 65(17): 495-498
Petit, H. 1973: Multiple sclerosis. Treatment Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 18(5): 548-549
Midgard, R. 2001: Treatment of multiple sclerosis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(19): 2254
Confavreux, C. 1994: Treatment of multiple sclerosis La Revue du Praticien 44(12): 1643-1648
Frick, E.; Angstwurm, H.; Strauss, G. 1974: Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin Münchener Medizinische Wochenschrift 116(48): 2105-2112
Martí-Vilalta, J.L.; Costa-Jussá, F.; Roig, C. 1981: Multiple sclerosis. Treatment interactions Medicina Clinica 77(6): 263
Silberberg, D.H. 1994: Specific treatment of multiple sclerosis Clinical Neuroscience 2(3-4): 271-274
Schapiro, R.T. 1999: Medications used in the treatment of multiple sclerosis Physical Medicine and Rehabilitation Clinics of North America 10(2): 437-446 Ix
Tanaka, M. 2014: Fingolimod treatment in multiple sclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 72(11): 2010-2014
Sivertseva, S.A.; Zhuravlev, M.N.; Shmurygina, E.A.; Dekhtiarenko, E.V.; Boĭko, A.N. 2009: Use of mitoxantrone in the treatment of multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(7 Suppl 2: 100-106
Meinl, E.; Voltz, R. 2004: Multiple sclerosis. Biomarkers for deciding treatment MMW Fortschritte der Medizin 146(Special Issue 2): 57-58